Dr Pradeep. V. Mahajan, Regenerative medicine researcher, StemRx Bioscience Solutions Pvt Ltd,has been selected for two conferences that will be held in China and Dubai respectively. Dr. Mahajan will be a part of BIT’s 10th World Congress of Regenerative Medicine and Stem Cells which will be held from November 16 to 19, 2016 in China. The second conference is a Global Forum on Transplantation Research and Technologies and will be held in Dubai from November 28 to 29, 2016.
Dr. Mahajan’s skills in regenerative medicine have proven to be innovative over the last few years. He has undergone multiple training in tissue culture, applied his innovation to develop stem cell therapeutics. Despite having crossed 50 years of age he is unstoppable and has been involved research in biosciences since last five years.
The conference in China is based on the theme- March in a new era of Permanent cure towards 2036. This conference is expected to attract more than 2000 participants from across the globe. Dr Mahajan is one of the speakers and will talk about MSC-the new drug on the horizon. Mesenchymal Stem Cells (MSC) are used to take complete charge of the damaged tissue, activate the body’s own repairing kits thus ensuring healing. Thus he will focus on the use of MSC therapeutically.
At the conference in Dubai he will be speaking on Regenerative medicine and cell based therapy- the future of organ transplant. The Global Forum on Transplantation Research and Technologies is organized by Clyto Access Inc at Dubai. This is to provide an international platform for the exchange of knowledge with the help of various meetings, workshops, seminars and exhibitions that focus on the various approaches in branches of organ transplantation. The conference will have well known scientists and researchers along with industries or companies that focus in transplantation research and technology. They will also highlight policies and issues relevant to development of transplant programs and organ donations.